DSM-Firmenich AG (LON:0AC9)

Market Cap	16.72B
Revenue (ttm)	11.15B
Net Income (ttm)	615.46M
Shares Out	n/a
EPS (ttm)	2.33
PE Ratio	27.17
Forward PE	19.15
Dividend	2.12 (2.84%)
Ex-Dividend Date	May 8, 2025

Volume	32,044
Average Volume	228,251
Open	75.43
Previous Close	74.61
Day's Range	75.08 - 75.96
52-Week Range	70.94 - 118.30
Beta	n/a
RSI	53.16
Earnings Date	Feb 12, 2026

About DSM-Firmenich AG

DSM-Firmenich AG provides nutrition, health, and beauty solutions in Switzerland, the Netherlands, rest of Europe, the Middle East and Africa, North America, Latin America, China, and rest of Asia. The company operates through four segments: Perfumery & Beauty; Taste, Texture & Health; Health, Nutrition & Care; and Animal Nutrition & Health. The Perfumery & Beauty creates scents using natural, synthetic, and biotech ingredients. The Taste, Texture & Health segment provides food and beverages solutions, including flavors, natural extracts, and s...

• Industry: Chemicals and Allied Products
• Founded: 1902
• Employees: 26,301
• Stock Exchange: London Stock Exchange
• Ticker Symbol: 0AC9

Financial Performance

In 2024, DSM-Firmenich AG's revenue was 12.80 billion, an increase of 20.44% compared to the previous year's 10.63 billion. Earnings were 250.00 million, a decrease of -88.27%.

Financial numbers in EUR